Home/Accutar Biotechnology/Yimin Qian, PhD

YQ

Yimin Qian, PhD

Chief Discovery Officer and Head of Chemistry

Accutar Biotechnology

Therapeutic Areas

Accutar Biotechnology Pipeline

Drug	Indication	Phase
AC699	ER+/HER2-, ESR1-mutated advanced or metastatic breast cancer	Phase 1

Leadership Team at Accutar Biotechnology

Founder and Chief Executive Officer

Chief Scientific Officer

Xiangyan Sun, MS

Chief Technology Officer

View full Accutar Biotechnology profile